Cytokinetics, Incorporated
CYTKNASDAQNASDAQ Global Select·USD·Closed
$63.19
−$2.41 (3.67%)
$63.19
−$2.41 (3.67%)
Not investment advice.Learn more
CYTK presents a mixed picture — bulls and bears both have arguments.
This company doesn't pay a dividend
A mid-sized company. Balances growth potential with stability
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Mid-cap company
P/E Ratio
Div Yield
No dividend